Summary
To determine whether individual subjects with Type 1 (insulin-dependent) diabetes or Type 2 (non-insulin-dependent) diabetes, who are treated with insulin, could be reliably distinguished, C-peptide concentrations and urinary C-peptide excretion were measured in 10 Caucasoids and 10 Pima Indians. All the subjects had developed diabetes before 21 years of age and were receiving insulin treatment. Fasting C-peptide concentrations were significantly higher in the Pima Indians (0.73±0.17 versus 0.02±0.01 nmol/l in Caucasoids; p<0.001), but there were slight overlaps in individual values. Urinary C-peptide excretion, an index of 24-h-insulin excretion, was also higher in the Pima Indian group (27.6±1.85 versus 0.72±0.18 pmol/min in Caucasoids; p<0.001) and there was no overlap in the individual values between the groups. The Pima Indians with early onset diabetes have been previously shown to have Type 2 diabetes, and the Caucasoids with an early onset are most likely to have Type 1 diabetes. These results suggest that distinction between these two major types of diabetes can be made effectively by using C-peptide measurements provided that overt renal disease is absent. This differentiation between insulin-treated patients will be useful for a variety of research applications and possibly in making clinical management decisions.
Article PDF
Similar content being viewed by others
References
Fajans SS, Floyd JC, Tattersall RB, Williamson JR, Pek S, Taylor CI (1976) The various faces of diabetes of the young. Arch Int Med 136: 194–202
Rotter JE, Rimoin DL (1978) Heterogeneity in diabetes mellitusupdate; evidence for further genetic heterogeneity within juvenile-onset insulin-dependent diabetes mellitus. Diabetes 27: 599–605
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
WHO Expert Committee on Diabetes Mellitus (1980) Second Report, Technical Report Series No. 640, Geneva
Savage PJ, Bennett PH, Senter RG, Miller M (1979) High prevalence of diabetes in young Pima Indians. Diabetes 28: 937–942
Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH (1977) Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26: 22–29
Horwitz D, Rubenstein AH, Katz AI (1977) Quantitation of human pancreatic beta-cell function by immunoassay of C-peptide in urine. Diabetes 26: 30–35
Terasaki PI, Bernoco A, Park MD, Ozturke G, Iwaki Y (1978) Microdrop testing for HLA-A, -B, -C, and -D antigens. Am J Clin Path 69: 103–120
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2: 1279–1283
Snedecor GW, Cochran WC (1976) Statistical Methods, 6 ed, State University Press, Ames, Iowa
Kajinuma H, Tanabashi S, Ishiwata K, Kuzuya N (1979) Urinary excretion of C-peptide in relation to renal function. In: Baba S, Koneko T, Yanihara N (eds) Pro-insulin, insulin, and C-peptide. Excerpta Medica, Amsterdam-Oxford, pp 183–189
Blix PM, Boddie-Willis C, Landau RL, Rochman H, Rubenstein AH (1982) Urinary C-peptide: an indicator of B-cell secretion under different metabolic conditions. J Clin Endocrinol Metab 54: 574–580
Knowler WC, Bennett PH, Bottazzo GF, Doniach D (1979) Islet cell antibodies and diabetes mellitus in Pima Indians. Diabetologia 17: 161–164
Miestas MT, Zadik A, Margolis S, Kowarski AA (1981) Correlation of urinary excretion of C-peptide with the integrated concentration and secretion rate of insulin. Diabetes 30: 639–643
Gerich JF, Charles MA, Grodsky GM (1976) Regulation of pancreatic insulin and glucagon secretion. Ann Rev Physiol 38: 353–388
Welborn T, Garcia-Webb P, Bousen AM (1981) Basal C-peptide in the discrimination of Type I from Type II diabetes. Diabetes Care 4: 616–619
Bantle JP, Laine DC, Hoogwerf BJ, Goetz FC (1984) The potential usefulness of postprandial urine C-peptide measurement in classifying diabetic patients. Diabetes Care 7: 202–203
Hendrikson C, Faber OK, Drejer J, Binder C (1977) The prevalence of residual beta-cell function in insulin treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon. Diabetologia 13: 615–616.
Rappaport EB, Ulstrom RA, Etzwiler DD, Fife D, Hudlund BE, Steffes MW (1980) Urine C-peptide, B-cell function, and insulin requirement. Am J Dis Child 134: 1129–1133
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Katzeff, H.L., Savage, P.J., Barclay-White, B. et al. C-peptide measurement in the differentiation of Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 28, 264–268 (1985). https://doi.org/10.1007/BF00271682
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00271682